Longtime NYBC Favorite for Neuropathy Gets Its Due
A 2013 review by neurology experts found confirmation of the benefits of acetylcarnitine (also called N-acetyl-L-carnitine) supplementation for diabetes-related neuropathy (=nerve pain and damage), for HIV and antiretroviral therapy-related neuropathies, for neuropathy caused as a side effect of chemotherapy, and for neuropathy caused by compression (like sciatica). According to the review, acetylcarnitine “represents a consistent therapeutic option for peripheral neuropathies.”
Furthermore, recent research on acetylcarnitine has provided new insights into how the supplement works to diminish the pain of neuropathy and promote the regrowth of damaged nerve tissue. That’s why the authors of the review conclude that the recently expanded knowledge about acetylcarnitine’s mechanism of action can open up “new pathways in the study of peripheral nerve disease management.”
We’re glad to see confirmation of earlier findings about the value of this supplement for conditions like the peripheral neuropathy experienced by people with HIV—NYBC has been recommending it for that purpose for many years.
We hope that this review will lead to even wider recognition in the medical community of the value of acetylcarnitine as a therapy for neuropathy. It’s time this supplement got its due!
Want to know more about amazing acetylcarnitine?
This blog has 26 related articles about acetylcarnitine!